Skip to main content
. 2004 Sep 9;54(2):129–140. doi: 10.1007/s00262-004-0583-z

Fig. 3.

Fig. 3

HER-2/neu overexpression of KS24.22 transfectant. HER-2/neu–specific immunofluorescence of HER-2/neu–transfected KS24.22 cells, together with nontransfected parental cell KS. The SkBr3.A2 breast cancer cell line, which expresses constitutively high levels of HER-2/neu, was included as a positive control.